Get the Stockscreener App
1.82
9.00%
-0.18
After Hours:
1.99
0.17
+9.34%
Mustang Bio Inc Stock (MBIO) Latest News
BRIEF—Mustang Bio sells assets; focuses on MB-109, MB-108 and MB-101 - The Pharma Letter
Mustang Bio (MBIO) Projected to Post Earnings on Monday - Defense World
Mustang Bio stock plunges to 52-week low at $2 - Investing.com
Mustang Bio stock plunges to 52-week low at $2 By Investing.com - Investing.com South Africa
Mustang Bio exits Worcester facility, sells assets to AbbVie By Investing.com - Investing.com Australia
Mustang Bio stock plunges 29% on lease termination news - MSN
Mustang Bio stock plunges 29% on lease termination news (MBIO:NASDAQ) - Seeking Alpha
Mustang Bio exits lease for Massachusetts facility, divests equipment - TipRanks
Mustang Bio to Exit Lease of Worcester, Mass. Manufacturing Facility -February 27, 2025 at 05:49 pm EST - Marketscreener.com
Mustang Bio to Exit Lease of Worcester, Mass. Manufacturing Facility - MarketWatch
Mustang Bio exits Worcester facility, sells assets to AbbVie - Investing.com
Mustang Bio Announces Sale of Fixed Assets and Exit of Facility - The Manila Times
Can Mustang Bio's $3M Financial Boost From Facility Exit Revitalize Its Cancer Therapy Pipeline? - StockTitan
Mustang Bio secures shareholder nod for warrant share issuance By Investing.com - Investing.com South Africa
Mustang Bio secures shareholder nod for warrant share issuance - Investing.com India
Mustang Bio (NASDAQ:MBIO) Stock Quotes, Forecast and News Summary - Benzinga
Mustang Bio stock plunges to 52-week low of $2.6 amid sharp decline - Investing.com Australia
Mustang Bio sells assets and ends lease with AbbVie - MSN
Mustang Bio Sells Assets to AbbVie, Transfers Lease - TipRanks
Mustang Bio stock plunges to 52-week low of $2.6 amid sharp decline By Investing.com - Investing.com South Africa
Mustang Bio regains compliance with Nasdaq minimum bid price requirement - MSN
Mustang Bio, Inc. Regains Compliance with Nasdaq Listing Requirements Following Recent Public Offering - Nasdaq
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire
Nasdaq Compliance Alert: Mustang Bio Clears Major Hurdle with $2.5M Equity Milestone - StockTitan
Mustang Bio Closes $8 Million Public Offering - citybiz
Mustang Bio, Inc. Completes Public Offering, Raising Approximately $8 Million for Cancer Cell Therapy Development - Nasdaq
Mustang Bio Announces Closing of $8 Million Public Offering - GlobeNewswire
Mustang Bio (MBIO) Secures Critical $8M Financing Through Strategic Share Offering - StockTitan
Mustang Bio sets terms for $8M public offering - MSN
Mustang Bio sets terms for $8M public offering By Investing.com - Investing.com Canada
Mustang Bio Prices $8 Mln Public Offering - Nasdaq
Mustang Bio Announces Pricing of $8 Million Public Offering - The Manila Times
Mustang Bio Announces Pricing of $8 Million Public Offering - Benzinga
Capital Raise Alert: Mustang Bio Secures Fresh $8M Funding Through Strategic Share & Warrant Offering - StockTitan
Mustang Bio says it needs additional funds to avoid bankruptcy - The Business Journals
Mustang Bio stock plunges to 52-week low of $4 - MSN
Stock market today: VerifyMe -14.42%, PTL -13.23% among biggest losers in early trading - Business Upturn
Mustang Bio Inc. Appoints Michael J. Zelefsky as Director -June 13, 2017 at 04:02 pm EDT - Marketscreener.com
Mustang Bio, Inc. Announces Management Changes -April 24, 2017 at 08:00 am EDT - Marketscreener.com
Mustang Bio, Inc. Appoints Peter Carney as the Interim Chief Accounting Officer -December 12, 2023 at 06:23 am EST - Marketscreener.com
Mustang Bio, Inc. Terminates Exclusive License Agreement with Regents of the University of California - Marketscreener.com
UBriGene Biosciences Inc. completed the acquisition of Worcester manufacturing facility of Mustang Bio, Inc. - Marketscreener.com
6.45%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):